Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087

This publication has 36 references indexed in Scilit:

• Pravastatin in HIV-Infected Patients Treated with Protease Inhibitors: A Placebo-Controlled Randomized Study
  HIV Research & Clinical Practice, 2007
• Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men—a randomized, placebo-controlled study
  AIDS, 2006
• Reduction of soluble P-selectin by statins is inversely correlated with the progression of coronary artery disease
  International Journal of Cardiology, 2006
• Inflammation, Atherosclerosis, and Coronary Artery Disease
  New England Journal of Medicine, 2005
• Effects of pravastatin on lipoproteins and endothelial function in patients receiving human immunodeficiency virus protease inhibitors
  American Heart Journal, 2004
• Short-Term Statin Therapy and Cardiac Function and Symptoms in Patients With Idiopathic Dilated Cardiomyopathy
  Circulation, 2004
• Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis
  BMJ, 2003
• Relationship Between Lipid Levels and Clinical Outcomes in the Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) Trial
  Circulation, 2002
• Reference Limits of Apolipoprotein A-I and Apolipoprotein B Using an IFCC Standardized Immunonephelometric Method
  Clinical Chemistry and Laboratory Medicine (CCLM), 1995
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987